• Definition
    • Endoscopic and histological signs of gastritis typically as a result of alteration in pyloric function (eg post-op)
    • Attributing symptoms is problematic, as most patients with bile reflux are asymptomatic
  • Incidence
    • symptoms may occur months or years after an index operation
  • Classification
    • Primary: de novo
    • Secondary: related to previous operation
  • Etiology
    • Due to regurgitation of bile into the stomach because of:
      • An incompetent pyloric sphincter
      • Abnormal duodenal motility
      • Operative changes –
        • Gastric surgery (gastroenterostomy (especially Billroth II), pyloroplasty)
        • Even lap cholecystectomy
    • Concomitant infection with H.pylori can cause increased inflammation
  • Clinical
    • Patients commonly asymptomatic
    • Abdo pain, bilious vomiting, weight loss
  • Pathology
    • Bile salts and lecithin cause gastric mucosal injury
  • Investigations
    • Endoscopy: Bx & CLO test
    • 24hr gastric pH &/or gastric bilirubin (or bile salt) monitoring
    • Scintigraphic detection of bile in stomach (bile reflux scan)
  • Management
    • Test for and eradicate H. pylori
    • Medical management (limited success):
      • Ursodeoxycholic acid → improves Sx but not histology
      • Sucralfate → improves histology, but not Sx
      • Rabeprazole (same results as sucralfate)
      • PG E2
      • Cholestyramine and alginates
    • Definitive management is surgery (revision & Roux-en-Y)
      • Get improved symptoms in 50-90%
      • Uncommon to ‘cure’ pt of all symptoms
      • Surgery for primary reflux is rare: ‘duodenal switch’
  • Prognosis / Natural Hx:
    • May be a risk factor the development of antral metaplastic gastritis
    • Improvement from surgery less likely in patients with delayed gastric emptying